We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRZO
276
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $5.38M | 0.07% |
+176,108
| New | +$6.38M |
|
277
Akebia Therapeutics
AKBA
$354M
| $5.37M | 0.07% |
+556,000
| New | +$5.1M |
|
|
BKS
278
DELISTED
Barnes & Noble
BKS
| $5.32M | 0.07% |
+439,185
| New | +$7.05M |
|
279
SBA Communications
SBAC
$19.2B
| $5.3M | 0.07% |
50,643
+48,423
| +2,181% | +$5.64M |
|
|
ODP
280
DELISTED
ODP
ODP
| $5.26M | 0.07% |
81,919
+58,146
| +245% | +$4.53M |
|
|
MKTO
281
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $5.26M | 0.07% |
+185,000
| New | +$5.22M |
|
282
Fulton Financial
FULT
$4.66B
| $5.2M | 0.07% |
430,000
+237,740
| +124% | +$2.99M |
|
283
AngloGold Ashanti
AU
$40.1B
| $5.16M | 0.07% |
+630,000
| New | +$4.66M |
|
284
Tower Semiconductor
TSEM
$24.8B
| $5.15M | 0.07% |
400,000
-580,428
| -59% | -$7.81M |
|
|
FMER
285
DELISTED
FIRSTMERIT CORP
FMER
| $5.12M | 0.07% |
+290,000
| New | +$5.44M |
|
286
CSX Corp
CSX
$93.4B
| $5.1M | 0.07% |
568,494
+527,634
| +1,291% | +$5.18M |
|
|
HOUS
287
PUT
DELISTED
Anywhere Real Estate
HOUS
| $5.08M | 0.07% |
135,000
+133,650
| +9,900% | +$5.82M |
|
|
288
PUT
Perrigo
PRGO
$1.4B
| $5.06M | 0.07% |
+32,200
| New | +$5.91M |
|
289
Micron Technology
MU
$930B
| $5.05M | 0.07% |
337,336
+106,966
| +46% | +$1.84M |
|
290
Commault Systems
CVLT
$4.88B
| $5.05M | 0.07% |
148,606
+47,384
| +47% | +$1.77M |
|
291
TG Therapeutics
TGTX
$7.96B
| $5.04M | 0.07% |
500,000
-30,000
| -6% | -$447K |
|
|
ODP
292
PUT
DELISTED
ODP
ODP
| $4.99M | 0.07% |
77,680
+77,645
| +221,843% | +$6.05M |
|
293
Arrow Electronics
ARW
$11.1B
| $4.97M | 0.07% |
89,982
+83,328
| +1,252% | +$4.63M |
|
|
SEE
294
DELISTED
Sealed Air
SEE
| $4.96M | 0.07% |
105,835
-13,860
| -12% | -$716K |
|
295
Olin
OLN
$2.11B
| $4.96M | 0.07% |
+294,806
| New | +$6.23M |
|
|
NVCN
296
DELISTED
Neovasc Inc.
NVCN
| $4.93M | 0.07% |
40
+6
| +18% | +$859K |
|
297
Adeia
ADEA
$2.94B
| $4.9M | 0.07% |
+571,158
| New | +$5.24M |
|
298
Televisa
TV
$1.48B
| $4.87M | 0.07% |
187,296
+61,400
| +49% | +$1.97M |
|
|
GPOR
299
DELISTED
Gulfport Energy Corp.
GPOR
| $4.84M | 0.07% |
163,136
-149,555
| -48% | -$5.15M |
|
|
XEC
300
DELISTED
CIMAREX ENERGY CO
XEC
| $4.83M | 0.07% |
+47,173
| New | +$5.02M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.